Form 4 Tracker
NEUROCRINE BIOSCIENCES INC
NBIX

59 insider filings · Latest: Aug 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 28, 2026Jul 30 9:29 PMLeslie V NorwalkDirector
Sale
1,250$182.01$227.5K1,588(D)

View →

Jul 10, 2026Jul 13 8:27 PMIngrid DelaetChief Regulatory Officer
Sale
4,367$181.02$790.5K16,225(D)

View →

Jul 9, 2026Jul 13 8:27 PMDarin LippoldtChief Legal Officer
Sale
10,000$179.60$1.8M54,729(D)

View →

Jul 10, 2026Jul 10 8:39 PMINGRID DELAET
Proposed Sale
4,367$180.55$788.5K

View →

Jul 9, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
8,433$178.72$1.5M16,225(D)

View →

Jul 8, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
2,737$178.54$488.7K16,225(D)

View →

Jul 7, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
3,401$178.57$607.3K16,225(D)

View →

Jul 9, 2026Jul 9 8:27 PMDARIN LIPPOLDT
Proposed Sale
10,000$178.24$1.8M

View →

Jul 7, 2026Jul 7 8:33 PMINGRID DELAET
Proposed Sale
14,571$174.10$2.5M

View →

Jun 29, 2026Jun 30 8:52 PMDarin LippoldtChief Legal Officer
Sale
9,800$170.16$1.7M54,729(D)

View →

Jun 26, 2026Jun 30 8:52 PMDarin LippoldtChief Legal Officer
Sale
200$169.57$33.9K54,729(D)

View →

Jun 29, 2026Jun 29 8:43 PMDARIN LIPPOLDT
Proposed Sale
9,800$168.52$1.7M

View →

Jun 26, 2026Jun 26 8:25 PMDARIN LIPPOLDT
Proposed Sale
200$164.18$32.8K

View →

Jun 5, 2026Jun 9 9:40 PMSHERWIN STEPHEN ADirector
Sale
25,000$165.32$4.1M15,860(D)

View →

Jun 4, 2026Jun 8 10:07 PMLeslie V NorwalkDirector
Sale
1,250$168.06$210.1K2,838(D)

View →

Jun 5, 2026Jun 5 8:31 PMSTEPHEN SHERWIN
Proposed Sale
25,000$167.35$4.2M

View →

Jun 2, 2026Jun 4 10:02 PMJulie CookeChief Human Resources Officer
Sale
36,937$156.22$5.8M22,374(D)

View →

Jun 1, 2026Jun 2 10:08 PMJude OnyiaChief Scientific Officer
Sale
11,000$160.25$1.8M25,846(D)

View →

May 29, 2026Jun 2 10:03 PMIngrid DelaetChief Regulatory Officer
Sale
2,261$156.71$354.3K16,225(D)

View →

Jun 2, 2026Jun 2 8:39 PMJULIE COOKE
Proposed Sale
36,937$161.00$5.9M

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 13, 2026Feb 17 10:44 PMSanjay Chandru KeswaniChief Medical Officer
Grant/Award
42,112$124.126,285(D)

View →

Jan 31, 2026Feb 3 11:22 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
2,0960(D)

View →

Jan 31, 2026Feb 3 11:21 PMEric BenevichChief Commercial Officer
Option Exercise
2,2940(D)

View →

Jan 31, 2026Feb 3 11:06 PMMatt AbernethyChief Financial Officer
Option Exercise
2,4370(D)

View →

Jan 31, 2026Feb 3 11:05 PMJulie CookeChief Human Resources Officer
Option Exercise
1,7410(D)

View →

Jan 31, 2026Feb 3 11:04 PMIngrid DelaetChief Regulatory Officer
Option Exercise
8010(D)

View →

Jan 31, 2026Feb 3 11:03 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
2,9270(D)

View →

Jan 31, 2026Feb 3 11:02 PMKevin Charles GormanDirector
Option Exercise
5,1420(D)

View →

Jan 31, 2026Feb 3 11:01 PMDarin LippoldtChief Legal Officer
Option Exercise
2,3730(D)

View →

Jan 31, 2026Feb 3 11:01 PMJude OnyiaChief Scientific Officer
Option Exercise
2380(D)

View →

Jan 16, 2026Jan 20 11:56 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
36,400$35.990(D)

View →

← Previous

Page 4 of 4